<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03977246</url>
  </required_header>
  <id_info>
    <org_study_id>OpenPlaceboCycling</org_study_id>
    <nct_id>NCT03977246</nct_id>
  </id_info>
  <brief_title>Effect of Open-placebo Intervention on Cycling Performance</brief_title>
  <official_title>The Effect of an Open-placebo Intervention on Cycling Time-trial Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of an open-label placebo intervention on cycling time-trial
      performance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study investigated the effect of open-placebo on cycling time-trial (TT) performance.
      Twenty-eight trained female cyclists completed a 1-km cycling TT following a control session
      or an open-placebo intervention. The intervention consisted of an individual presentation,
      provided by a medic, in which the concept of open-placebo was explained to the participant,
      before she ingested two red and white capsules containing flour; 15 min later, they performed
      the TT. In the control session, the participant sat quietly for 20 min.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Actual">September 30, 2018</completion_date>
  <primary_completion_date type="Actual">August 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exercise performance</measure>
    <time_frame>20-min following open-placebo intervention</time_frame>
    <description>Change in 1 km cycling time-trial performance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood lactate</measure>
    <time_frame>Immediately post-exercise</time_frame>
    <description>Change in blood lactate concentration</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Exercise Performance</condition>
  <arm_group>
    <arm_group_label>Open-placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The open-placebo intervention session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control session</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Open-placebo</intervention_name>
    <description>Application of the open-placebo intervention</description>
    <arm_group_label>Open-placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Application of the control session</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females aged between 18 and 45 years old;

          -  A minimum of one-year training experience in cycling.

        Exclusion Criteria:

          -  Smokers

          -  Chronic disease

          -  Prior or current use of steroids

          -  Use of creatine in the last 6 months

          -  Use of beta-alanine in the last 6 months
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Gualano, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05508-30</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>School of Physical Education and Sport - USP</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05508030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 4, 2019</study_first_submitted>
  <study_first_submitted_qc>June 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2019</study_first_posted>
  <last_update_submitted>June 5, 2019</last_update_submitted>
  <last_update_submitted_qc>June 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Bruno Gualano</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

